HAL

HAL Allergy Group is a leading European pharmaceutical company specializing in the development, production, and distribution of allergen-specific immunotherapies (AIT). The company focuses on treating the underlying causes of allergic diseases such as hay fever, asthma, and insect venom allergies through subcutaneous (SCIT) and sublingual (SLIT) administration routes. HAL Allergy operates a modern GMP-certified manufacturing facility and provides contract manufacturing services for biopharmaceuticals, particularly for clinical trial materials. Their product portfolio includes well-known brands like PURETHAL and VENOMENHAL, serving patients across major European markets.